Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 61

1.

From ANA-screening to antigen-specificity: an EASI-survey on the daily practice in European countries.

Damoiseaux J, Agmon-Levin N, Van Blerk M, Chopyak V, Eriksson C, Heijnen I, Herold M, Høgåsen K, Musset L, Radice A, Rego de Sousa MJ, Viander M, Shoenfeld Y.

Clin Exp Rheumatol. 2014 Jul-Aug;32(4):539-46. Epub 2014 Jun 30.

PMID:
24983380
2.

Rescue of kidney function in a toddler with anti-GBM nephritis.

Bjerre A, Høgåsen K, Grøtta J, Scott H, Tangeraas T, Dörje C.

Clin Kidney J. 2012 Dec;5(6):584-586.

3.

[A 52-year old woman with fever and respiratory failure].

Ødegård IL, Høgåsen K, Paulsen D, Scott H.

Tidsskr Nor Laegeforen. 2009 Nov 19;129(22):2369-72. doi: 10.4045/tidsskr.09.0167. Norwegian. No abstract available.

4.

[Doppler sonography of arteriovenous fistulas for haemodialysis].

Edenberg J, Benschop P, Høgåsen K.

Tidsskr Nor Laegeforen. 2009 Aug 27;129(16):1635-8. doi: 10.4045/tidsskr.09.34272. Review. Norwegian.

6.

Complement activation directly induced by Helicobacter pylori.

Berstad AE, Høgåsen K, Bukholm G, Moran AP, Brandtzaeg P.

Gastroenterology. 2001 Apr;120(5):1108-16.

PMID:
11266375
7.

Increased systemic activation of neutrophils but not complement in preeclampsia.

Mellembakken JR, Høgåsen K, Mollnes TE, Hack CE, Abyholm T, Videm V.

Obstet Gynecol. 2001 Mar;97(3):371-4.

PMID:
11239639
8.

Interaction between human complement and a pectin type polysaccharide fraction, PMII, from the leaves of Plantago major L.

Michaelsen TE, Gilje A, Samuelsen AB, Høgåsen K, Paulsen BS.

Scand J Immunol. 2000 Nov;52(5):483-90.

9.

The analysis of the complement activation product SC5 b-9 is applicable in neonates in spite of their profound C9 deficiency.

Høgåsen AK, Overlie I, Hansen TW, Abrahamsen TG, Finne PH, Høgåsen K.

J Perinat Med. 2000;28(1):39-48.

PMID:
10765513
10.
11.

Compstatin, a peptide inhibitor of C3, prolongs survival of ex vivo perfused pig xenografts.

Fiane AE, Mollnes TE, Videm V, Hovig T, Høgåsen K, Mellbye OJ, Spruce L, Moore WT, Sahu A, Lambris JD.

Xenotransplantation. 1999 Feb;6(1):52-65.

PMID:
10355733
12.

Prolongation of ex vivo-perfused pig xenograft survival by the complement inhibitor Compstatin.

Fiane AE, Mollnes TE, Videm V, Hovig T, Høgåsen K, Mellbye OJ, Spruce L, Moore WT, Sahu A, Lambris JD.

Transplant Proc. 1999 Feb-Mar;31(1-2):934-5. No abstract available.

PMID:
10083413
13.

Anti-TNF treatment of baboons with sepsis reduces TNF-alpha, IL-6 and IL-8, but not the degree of complement activation.

Bengtsson A, Redl H, Schlag G, Högåsen K, Götze O, Mollnes TE.

Scand J Immunol. 1998 Nov;48(5):509-14.

14.

High-dose intravenous immunoglobulin treatment activates complement in vivo.

Mollnes TE, Høgåsen K, De Carolis C, Vaquero E, Nielsen EW, Fontana L, Perricone R.

Scand J Immunol. 1998 Sep;48(3):312-7.

15.

Characterization of soluble terminal complement complex assembled in C8beta-deficient plasma and serum.

Høgåsen K, Mollnes TE, Nürnberger W, Pausa M, Fukumori Y, Tedesco F.

Scand J Immunol. 1998 Sep;48(3):261-8.

16.

Local and systemic reactions after lung contusion: an experimental study in the pig.

Obertacke U, Neudeck F, Majetschak M, Hellinger A, Kleinschmidt C, Schade FU, Høgasen K, Jochum M, Strohmeier W, Thurnher M, Redl H, Schlag G.

Shock. 1998 Jul;10(1):7-12.

PMID:
9688084
17.

Effect of soluble complement receptor type 1 on reperfusion edema and neutrophil migration after lung allotransplantation in swine.

Schmid RA, Zollinger A, Singer T, Hillinger S, Leon-Wyss JR, Schöb OM, Høgåsen K, Zünd G, Patterson GA, Weder W.

J Thorac Cardiovasc Surg. 1998 Jul;116(1):90-7.

18.

Involvement of antilipoarabinomannan antibodies in classical complement activation in tuberculosis.

Hetland G, Wiker HG, Høgåsen K, Hamasur B, Svenson SB, Harboe M.

Clin Diagn Lab Immunol. 1998 Mar;5(2):211-8.

19.
20.

In situ complement activation in porcine membranoproliferative glomerulonephritis type II.

Jansen JH, Høgåsen K, Harboe M, Hovig T.

Kidney Int. 1998 Feb;53(2):331-49.

21.

Effect of whole and fractionated intravenous immunoglobulin on complement in vitro.

Mollnes TE, Andreassen IH, Høgåsen K, Hack CE, Harboe M.

Mol Immunol. 1997 Jul;34(10):719-29.

PMID:
9430199
22.

Eradication of porcine factor H deficiency in Norway.

Høgåsen K, Jansen JH, Harboe M.

Vet Rec. 1997 Apr 12;140(15):392-5.

PMID:
9141221
23.

Acquired C3 deficiency in patients with alcoholic cirrhosis predisposes to infection and increased mortality.

Homann C, Varming K, Høgåsen K, Mollnes TE, Graudal N, Thomsen AC, Garred P.

Gut. 1997 Apr;40(4):544-9.

24.

Both plasma- and leukocyte-associated C5a are essential for assessment of C5a generation in vivo.

Hetland G, Moen O, Bergh K, Högäsen K, Hack CE, Mollnes TE, Fosse E.

Ann Thorac Surg. 1997 Apr;63(4):1076-80.

PMID:
9124908
25.

Infection with human cytomegalovirus (HCMV) stimulates monocyte production of complement factor 3.

Holberg-Petersen M, Høgåsen AK, Høgåsen K, Abrahamsen TG, Degré M, Rollag H.

Arch Virol. 1997;142(4):689-98.

PMID:
9170497
27.

Attenuation of changes in leukocyte surface markers and complement activation with heparin-coated cardiopulmonary bypass.

Moen O, Høgåsen K, Fosse E, Dregelid E, Brockmeier V, Venge P, Harboe M, Mollnes TE.

Ann Thorac Surg. 1997 Jan;63(1):105-11.

PMID:
8993250
28.

Centrifugal pump and heparin coating improves cardiopulmonary bypass biocompatibility.

Moen O, Fosse E, Dregelid E, Brockmeier V, Andersson C, Høgåsen K, Venge P, Mollnes TE, Kierulf P.

Ann Thorac Surg. 1996 Oct;62(4):1134-40.

PMID:
8823102
29.
30.

Activation of the complement, coagulation, fibrinolytic and kallikrein-kinin systems during attacks of hereditary angioedema.

Nielsen EW, Johansen HT, Høgåsen K, Wuillemin W, Hack CE, Mollnes TE.

Scand J Immunol. 1996 Aug;44(2):185-92.

PMID:
8711433
31.

Activation of the complement, coagulation, fibrinolytic and kallikrein-kinin systems during attacks of hereditary angioedema.

Nielsen EW, Johansen HT, Høgåsen K, Wuillemin W, Hack CE, Mollnes TE.

Immunopharmacology. 1996 Jun;33(1-3):359-60. No abstract available.

PMID:
8856186
32.

Serum clusterin and vitronectin in alcoholic cirrhosis.

Høgåsen K, Homann C, Mollnes TE, Graudal N, Høgåsen AK, Hasselqvist P, Thomsen AC, Garred P.

Liver. 1996 Apr;16(2):140-6.

PMID:
8740849
33.

Differences in blood activation related to roller/centrifugal pumps and heparin-coated/uncoated surfaces in a cardiopulmonary bypass model circuit.

Moen O, Fosse E, Bråten J, Andersson C, Høgåsen K, Mollnes TE, Venge P, Kierulf P.

Perfusion. 1996 Mar;11(2):113-23.

PMID:
8740352
34.

The excessive complement activation in fulminant meningococcal septicemia is predominantly caused by alternative pathway activation.

Brandtzaeg P, Høgåsen K, Kierulf P, Mollnes TE.

J Infect Dis. 1996 Mar;173(3):647-55.

PMID:
8627028
35.
36.

C3 is activated in hereditary angioedema, and C1/C1-inhibitor complexes rise during physical stress in untreated patients.

Nielsen EW, Johansen HT, Gaudesen O, Osterud B, Olsen JO, Høgåsen K, Hack CE, Mollnes TE.

Scand J Immunol. 1995 Dec;42(6):679-85.

PMID:
8552992
37.

Disparity in blood activation by two different heparin-coated cardiopulmonary bypass systems.

Moen O, Fosse E, Brockmeier V, Andersson C, Mollnes TE, Høgåsen K, Venge P.

Ann Thorac Surg. 1995 Nov;60(5):1317-23.

PMID:
8526620
38.

Porcine membranoproliferative glomerulonephritis type II: an autosomal recessive deficiency of factor H.

Jansen JH, Høgåsen K, Grøndahl AM.

Vet Rec. 1995 Sep 2;137(10):240-4.

PMID:
8533215
39.

A new model for evaluation of biocompatibility: combined determination of neoepitopes in blood and on artificial surfaces demonstrates reduced complement activation by immobilization of heparin.

Mollnes TE, Riesenfeld J, Garred P, Nordström E, Høgåsen K, Fosse E, Götze O, Harboe M.

Artif Organs. 1995 Sep;19(9):909-17.

PMID:
8687297
40.

Effect of syringe-assisted liposuction on activation of cascade systems and circulating cells when using the superwet or tumescent technique.

Samdal F, Aasen AO, Mollnes TE, Høgåsen K, Amland PF.

Ann Plast Surg. 1995 Sep;35(3):242-8.

PMID:
7503516
41.

Inhibition of complement-mediated red cell lysis by immunoglobulins is dependent on the IG isotype and its C1 binding properties.

Mollnes TE, Høgåsen K, Hoaas BF, Michaelsen TE, Garred P, Harboe M.

Scand J Immunol. 1995 May;41(5):449-56. Erratum in: Scand J Immunol 1995 Dec;42(6):705.

PMID:
7725063
42.

Hereditary porcine membranoproliferative glomerulonephritis type II is caused by factor H deficiency.

Høgåsen K, Jansen JH, Mollnes TE, Hovdenes J, Harboe M.

J Clin Invest. 1995 Mar;95(3):1054-61.

43.

Transforming growth factor beta modulates C3 and factor B biosynthesis and complement receptor 3 expression in cultured human monocytes.

Høgåsen AK, Hestdal K, Høgåsen K, Abrahamsen TG.

J Leukoc Biol. 1995 Feb;57(2):287-96.

PMID:
7852844
44.

The Fluid-phase SC5b-9 Terminal Complement Complex Binds to the GPIIb/IIIa Complex of Thrombin-stimulated Human Blood Platelets Inhibiting Platelet Aggregation.

Røger M, Høgåsen K, Holme PA, Halstensen TS, Mollnes TE, Hovig T.

Platelets. 1995;6(3):160-8. doi: 10.3109/09537109509013269.

PMID:
21043620
45.

Fatal myocardial depression and circulatory collapse associated with complement activation induced by plasma infusion in severe porcine sepsis.

Busund R, Balteskard L, Rønning G, Høgåsen K, Revhaug A.

Acta Anaesthesiol Scand. 1995 Jan;39(1):100-8.

PMID:
7725871
46.

Terminal complement pathway activation and low lysis inhibitors in rheumatoid arthritis synovial fluid.

Høgåsen K, Mollnes TE, Harboe M, Götze O, Hammer HB, Oppermann M.

J Rheumatol. 1995 Jan;22(1):24-8.

PMID:
7535360
48.

Complement-mediated permeabilization of platelets by monoclonal antibodies to CD9: inhibition by leupeptin, and effects on the GP Ib-actin-binding protein system.

Solum NO, Rubach-Dahlberg E, Pedersen TM, Reisberg T, Høgåsen K, Funderud S.

Thromb Res. 1994 Aug 15;75(4):437-52.

PMID:
7997982
49.

Roller and centrifugal pumps compared in vitro with regard to haemolysis, granulocyte and complement activation.

Moen O, Fosse E, Bråten J, Andersson C, Fagerhol MK, Venge P, Høgåsen K, Mollnes TE.

Perfusion. 1994 Mar;9(2):109-17.

PMID:
7919596

Supplemental Content

Loading ...
Support Center